Castle Biosciences Inc

NASDAQ:CSTL   12:59:21 PM EDT
42.93
-1.93 (-4.30%)
Earnings Announcements

Castle Biosciences Reports Q3 Revenue Of $23.5 Mln

Published: 11/08/2021 21:38 GMT
Castle Biosciences Inc (CSTL) - Castle Biosciences Announces Third Quarter 2021 Results.
Q3 Revenue Rose 54 Percent to $23.5 Million.
On Track to Achieve 2021 Total Revenue Guidance of $89-$93 Million.
Qtrly Loss per Share $0.47.
Q3 Earnings per Share View $-0.41, Revenue View $23.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $23.65 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $24.87 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.